FDA recalls antihistamine tablets. Here are the affected products.

FDA recalls antihistamine tablets, potentially including Zyrtec and other brands.

Unique Pharmaceutical Laboratories has issued a voluntary nationwide recall of select lots of Cetirizine Hydrochloride Tablets (5 mg) due to potential cross-contamination with the heartburn drug ranitidine. While no adverse events have been reported, consumers with a hypersensitivity to ranitidine face potential life-threatening allergic reactions if they consume the affected medication.

1. Identification of the Issue

   The contamination was discovered by an observant pharmacy technician who noticed physical discrepancies, specifically red markings and discoloration, on the tablets while dispensing them.

2. Specific Brands and Lots Affected

   The recall specifically impacts four lots of generic 5 mg Cetirizine Hydrochloride tablets (lots GY825029, GY825030, GY825031, and GY825032) distributed nationwide by Rising Pharma Holdings Inc. in 100-tablet bottles.

3. Severe Allergic Risks

   For the general population, a stray ranitidine pill is low risk, but for those with a ranitidine hypersensitivity, it can trigger severe reactions including throat swelling, rapid blood pressure drops (hypotension), and anaphylaxis.

4. How Consumers Can Check

   Standard amber pharmacy prescription bottles do not list manufacturer lot numbers; consumers are advised to check their labels for "Rising Pharma Holdings Inc." or contact their pharmacists directly to verify if their supply is safe.

5. Alternative Solution:

Kure-it V-Sheild is a natural alternative to over the counter and prescription nasal sprays. It coats and sooths inflammation and helps keep passages clear. Unlike chemical brands, it also promotes healthy tissues providing much needed nutrients directly where they are needed. Click here to try it now!